Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000706218 | SCV000835257 | likely pathogenic | 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency | 2023-03-22 | criteria provided, single submitter | clinical testing | This variant is present in population databases (rs764433016, gnomAD 0.001%). This sequence change replaces threonine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 120 of the SRD5A2 protein (p.Thr120Pro). This missense change has been observed in individuals with 5-alpha-reductase deficiency (PMID: 21402750). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SRD5A2 protein function. ClinVar contains an entry for this variant (Variation ID: 582210). |
Clinical Biochemistry Laboratory, |
RCV000706218 | SCV004190299 | pathogenic | 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency | 2023-11-20 | criteria provided, single submitter | clinical testing | ACMG:PS5 PM2 PM3 PP4 PP5 |